Sign In
Get Clay Free →

Suggestions

    Chris Abbosh

    Oncology Clinician Scientist MD/PhD

    Chris Abbosh is a prominent researcher and medical professional specializing in cancer genetics and circulating tumor DNA (ctDNA). He currently holds the position of Executive Director of Oncology R&D Strategy at AstraZeneca.34 Abbosh has a background as a medical doctor (MD) and holds a PhD.3

    His research focuses on:

    1. Lung cancer evolution and metastasis
    2. Use of ctDNA as a biomarker for cancer detection and monitoring
    3. Immunotherapy and cancer treatment strategies

    Abbosh has made significant contributions to the field of cancer research, particularly in tracking the evolution of non-small cell lung cancer and developing methods for early detection using ctDNA.1 His work has been widely cited, with several highly influential publications in prestigious journals such as Nature, New England Journal of Medicine, and Cancer Cell.1

    In addition to his role at AstraZeneca, Abbosh has been involved in various research collaborations and has received funding from organizations like Stand Up To Cancer and Cancer Research UK.2 He has also served as a speaker and advisory board member for pharmaceutical companies, including Novartis, Roche Diagnostics, and Bristol Myers Squibb.2

    Abbosh's LinkedIn profile indicates that he is based in the United Kingdom and has over 500 connections in the professional network.4

    Highlights

    ‪Chris Abbosh‬ - ‪Google Scholar‬
    Oct 12 · journals.plos.org
    ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors

    Related Questions

    What are Chris Abbosh's main research interests?
    How has Chris Abbosh contributed to the field of cancer genetics?
    What is the significance of Chris Abbosh's work on ctDNA?
    How does Chris Abbosh's research impact cancer treatment strategies?
    What are some notable publications by Chris Abbosh?
    Chris Abbosh
    Add to my network

    Location

    United Kingdom